Abstract
We have compared the efficacy of daily injection of recombinant leptin protein (rh-leptin) with adenovirus-mediated delivery of the murine or human leptin gene (Ad-leptin) for treatment of obesity in the obese (ob/ob) mouse model. We demonstrate an improved correction profile for obesity and associated surrogate markers using the adenovirus delivery method. Rate of weight loss and percentage satiety were significantly greater in the mice treated with Ad-leptin. These findings were associated with lower peak serum leptin levels with Ad-leptin (22.9 ± 2.6 ng/ml for the human gene, and 48.9 ± 11.5 ng/ml for the murine gene) compared to rh-leptin (385.2 ± 36.0 ng/ml). (Values are given as mean ± standard error of the mean.) Importantly, rh-leptin and ex vivo-expressed Ad-leptin were equivalently active in a functional cell-based assay. The primary difference in the two therapeutic approaches is the continuous chronic secretion of leptin mediated by gene delivery, versus the intermittent bolus delivery and rapid clearance of the daily injection of rh-leptin protein. Thus, in vivo findings suggest that leptin effects are better achieved at lower steady-state levels, a pharmacological feature attained here by gene therapy. These findings may have implications for the potential use of leptin in the treatment of obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morsy, M., Gu, M., Zhao, J. et al. Leptin gene therapy and daily protein administration: a comparative study in the ob/ob mouse. Gene Ther 5, 8–18 (1998). https://doi.org/10.1038/sj.gt.3300565
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300565
Keywords
This article is cited by
-
Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection
Gene Therapy (2022)
-
Treatment of Obesity and Diabetes in Mice by Transplant of Gut Cells Engineered to Produce Leptin
Molecular Therapy (2008)
-
Hypothalamic delivery of doxycycline-inducible leptin gene allows for reversible transgene expression and physiological responses
Gene Therapy (2002)